Development and validation of an efficient in-house real-time reverse transcription polymerase chain reaction assay for the quantitative detection of serum hepatitis delta virus RNA in a diverse South London population

Journal of Virological Methods

Volumn 184, Issue 1-2, 2012, Pages 55-62

  Shang, Dazhuang ^a   Hughes, Sarah A ^a   Horner, Mary ^a   Bruce, Matthew J ^a   Dong, Yan ^b   Carey, Ivana ^c   Suddle, Abid R ^a   Agarwal, Kosh ^a   Harrison, Phillip M ^c   Atkins, Mark ^a,d  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Genotype; Hepatitis delta virus; Quantitation; RNA; RT PCR; Sequencing

Indexed keywords

VIRUS RNA;

AMPLICON; ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; GENOTYPE; HEPATITIS DELTA VIRUS; HEPATITIS DELTA VIRUS 1; HEPATITIS DELTA VIRUS 5; HEPATITIS DELTA VIRUS 6; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SERUM; UNITED KINGDOM; VALIDATION PROCESS; VALIDATION STUDY; VIRUS IDENTIFICATION;

HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; LONDON; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SERUM; VIRAL LOAD;

HEPATITIS DELTA VIRUS;

EID: 84863821114     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.05.008     Document Type: Article

References (34)

1. Casey J.L., Brown T.L., Colan E.J., Wignall F.S., Gerin J.L. A genotype of hepatitis D virus that occurs in northern South America. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:9016-9020.
2. Castelnau C., Le Gal F., Ripault M.P., Gordien E., Martinot-Peignoux M., Boyer N., Pham B.N., Maylin S., Bedossa P., Deny P., Marcellin P., Gault E. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006, 44:728-735.
3. Chevaliez S., Pawlotsky J.M. How to use virological tools for optimal management of chronic hepatitis C. Liver International 2009, 29(Suppl. 1):9-14.
4. Cross T.J., Rizzi P., Horner M., Jolly A., Hussain M.J., Smith H.M., Vergani D., Harrison P.M. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. Journal of Medical Virology 2008, 80:277-282.
5. Deny P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades?. Current Topics in Microbiology and Immunology 2006, 307:151-171.
6. Dimech W., Bowden D.S., Brestovac B., Byron K., James G., Jardine D., Sloots T., Dax E.M. Validation of assembled nucleic acid-based tests in diagnostic microbiology laboratories. Pathology 2004, 36:45-50.
7. Erhardt A., Gerlich W., Starke C., Wend U., Donner A., Sagir A., Heintges T., Haussinger D. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver International 2006, 26:805-810.
8. Gault E., Michel Y., Dehee A., Belabani C., Nicolas J.C., Garbarg-Chenon A. Quantification of human cytomegalovirus DNA by real-time PCR. Journal of Clinical Microbiology 2001, 39:772-775.
9. Hofmann J., Frenzel K., Minh B.Q., von Haeseler A., Edelmann A., Ross S.R., Berg T., Kruger D.H., Meisel H. Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysis. Diagnostic Microbiology and Infectious Disease 2010, 67:172-179.
10. Imazeki F., Omata M., Ohto M. Heterogeneity and evolution rates of delta virus RNA sequences. Journal of Virology 1990, 64:5594-5599.
11. Kamath R.S., Ahringer J. Genome-wide RNAi screening in Caenorhabditis elegans. Methods 2003, 30:313-321.
12. Le Gal F., Gault E., Ripault M.P., Serpaggi J., Trinchet J.C., Gordien E., Deny P. Eighth major clade for hepatitis delta virus. Emerging Infectious Diseases 2006, 12:1447-1450.
13. Le Gal F., Gordien E., Affolabi D., Hanslik T., Alloui C., Deny P., Gault E. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. Journal of Clinical Microbiology 2005, 43:2363-2369.
14. Manesis E.K., Schina M., Le Gal F., Agelopoulou O., Papaioannou C., Kalligeros C., Arseniou V., Manolakopoulos S., Hadziyannis E.S., Gault E., Koskinas J., Papatheodoridis G., Archimandritis A.J. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Antiviral Therapy 2007, 12:381-388.
15. Mederacke I., Bremer B., Heidrich B., Kirschner J., Deterding K., Bock T., Wursthorn K., Manns M.P., Wedemeyer H. Establishment of a novel quantitative HDV RNA assay using the COBAS TaqMan platform to study HDV RNA kinetics. Journal of Clinical Microbiology 2010, 48:2022-2029.
16. Papin J.F., Vahrson W., Dittmer D.P. SYBR green-based real-time quantitative PCR assay for detection of West Nile Virus circumvents false-negative results due to strain variability. Journal of Clinical Microbiology 2004, 42:1511-1518.
17. Parana R., Kay A., Molinet F., Viana S., Silva L.K., Salcedo J.M., Tavares-Neto J., Lobato C., Rios-Leite M., Matteoni L., D'Oliveira A., Tauil P., Trepo C. HDV genotypes in the Western Brazilian Amazon region: a preliminary report. American Journal of Tropical Medicine and Hygiene 2006, 75:475-479.
18. Pawlotsky J.M. Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. Journal of Hepatology 2003, 39(Suppl. 1):S31-S35.
19. http://www.qiagen.com/resources/info/guidelines_rtpcr/quantifying.aspx.
20. Radjef N., Gordien E., Ivaniushina V., Gault E., Anais P., Drugan T., Trinchet J.C., Roulot D., Tamby M., Milinkovitch M.C., Deny P. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. Journal of Virology 2004, 78:2537-2544.
21. Rizzetto M. Hepatitis D: thirty years after. Journal of Hepatology 2009, 50:1043-1050.
22. Sakugawa H., Nakasone H., Nakayoshi T., Kawakami Y., Miyazato S., Kinjo F., Saito A., Ma S.P., Hotta H., Kinoshita M. Hepatitis delta virus genotype IIb predominates in an endemic area, Okinawa, Japan. Journal of Medical Virology 1999, 58:366-372.
23. Schaper M., Rodriguez-Frias F., Jardi R., Tabernero D., Homs M., Ruiz G., Quer J., Esteban R., Buti M. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. Journal of Hepatology 2010, 52:627-629.
24. Shakil A.O., Hadziyannis S., Hoofnagle J.H., Di Bisceglie A.M., Gerin J.L., Casey J.L. Geographic distribution and genetic variability of hepatitis delta virus genotype I. Virology 1997, 234:160-167.
25. Su C.W., Huang Y.H., Huo T.I., Shih H.H., Sheen I.J., Chen S.W., Lee P.C., Lee S.D., Wu J.C. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 2006, 130:1625-1635.
26. Sureau C. The role of the HBV envelope proteins in the HDV replication cycle. Current Topics in Microbiology and Immunology 2006, 307:113-131.
27. Takeuchi T., Katsume A., Tanaka T., Abe A., Inoue K., Tsukiyama-Kohara K., Kawaguchi R., Tanaka S., Kohara M. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 1999, 116:636-642.
28. Wang K.S., Choo Q.L., Weiner A.J., Ou J.H., Najarian R.C., Thayer R.M., Mullenbach G.T., Denniston K.J., Gerin J.L., Houghton M. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature 1986, 323:508-514.
29. Watanabe H., Nagayama K., Enomoto N., Chinzei R., Yamashiro T., Izumi N., Yatsuhashi H., Nakano T., Robertson B.H., Nakasone H., Sakugawa H., Watanabe M. Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. Journal of General Virology 2003, 84:3275-3289.
30. Wedemeyer H., Yurdaydin C., Dalekos G.N., Erhardt A., Cakaloglu Y., Degertekin H., Gurel S., Zeuzem S., Zachou K., Bozkaya H., Koch A., Bock T., Dienes H.P., Manns M.P. Peginterferon plus adefovir versus either drug alone for hepatitis delta. New England Journal of Medicine 2011, 364:322-331.
31. Weiner A.J., Choo Q.L., Wang K.S., Govindarajan S., Redeker A.G., Gerin J.L., Houghton M. A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. Journal of Virology 1988, 62:594-599.
32. Wu J.C. Functional and clinical significance of hepatitis D virus genotype II infection. Current Topics in Microbiology and Immunology 2006, 307:173-186.
33. Wu J.C., Chiang T.Y., Sheen I.J. Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. Journal of General Virology 1998, 79(Pt 5):1105-1113.
34. Yamashiro T., Nagayama K., Enomoto N., Watanabe H., Miyagi T., Nakasone H., Sakugawa H., Watanabe M. Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction - and its possible correlation with the clinical stage of liver disease. Journal of Infectious Diseases 2004, 189:1151-1157.